Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE)

Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE)

10.1371/journal.pone.0006811

Saved in:

Bibliographic Details
Main Authors:	Dickhaut K., Hoepner S., Eckhard J., Wiesmueller K.-H., Schindler L., Jung G., Falk K., Roetzschke O.
Other Authors:	MICROBIOLOGY AND IMMUNOLOGY
Format:	Article
Published:	2019
Subjects:	adamantane HLA DR antigen HLA DR1 antigen HLA DR4 antigen major histocompatibility antigen major histocompatibility antigen class 2 NY ESO 1 antigen tumor antigen cancer vaccine HLA antigen class 2 subunit vaccine animal cell animal experiment animal model antibody combining site antigen presenting cell article catalysis CD4+ T lymphocyte controlled study dendritic cell immune response in vivo study Influenza virus ligand binding mouse nonhuman transgenic mouse animal Bagg albino mouse cell proliferation cell separation chemistry CpG island human immunology immunotherapy methodology neoplasm tumor cell line Murinae Mus Orthomyxoviridae Animals Cancer Vaccines CD4-Positive T-Lymphocytes Cell Line, Tumor Cell Proliferation Cell Separation CpG Islands Histocompatibility Antigens Class II Humans Immunotherapy Mice Mice, Inbred BALB C Mice, Transgenic Neoplasms Vaccines, Subunit
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/161829
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Be the first to leave a comment!